Brachial-ankle pulse wave velocity and rate of renal function decline and mortality in chronic kidney disease

Szu-Chia Chen1, Jer-Ming Chang, Wan-Chun Liu

  • 1Division of Nephrology, Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

Insights

Arterial stiffness, measured by brachial-ankle pulse wave velocity (baPWV), independently predicts faster kidney function decline and progression to dialysis or death in chronic kidney disease (CKD) patients. Screening with baPWV can identify high-risk individuals.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biomedical Engineering

Background:

  • Arterial stiffness is linked to reduced kidney function (eGFR).
  • Previous research suggests arterial stiffness may influence chronic kidney disease (CKD) progression.
  • The role of arterial stiffness in CKD progression requires further investigation.

Purpose of the Study:

  • To determine if brachial-ankle pulse wave velocity (baPWV), a marker of arterial stiffness, is independently associated with renal function decline in CKD patients.
  • To assess the predictive value of baPWV for progression to dialysis or death in CKD.
  • To investigate the relationship between baPWV and estimated glomerular filtration rate (eGFR) slope.

Main Methods:

  • A longitudinal study involving 145 patients with CKD stages 3-5.
  • Brachial-ankle pulse wave velocity (baPWV) measured using an ABI-form device.
  • Renal function change estimated by eGFR slope; study endpoints were dialysis initiation or death.

Main Results:

  • Multivariate analysis showed eGFR slope negatively associated with baPWV (β=-0.165, P=0.033).
  • Higher baPWV was independently associated with progression to dialysis or death (HR, 1.001; P=0.001) in Cox regression.
  • Lower baseline eGFR and higher serum phosphate also predicted progression.

Conclusions:

  • Brachial-ankle pulse wave velocity (baPWV) is independently associated with renal function decline in CKD patients.
  • Higher baPWV predicts progression to dialysis or death in CKD.
  • baPWV screening can identify CKD patients at high risk for rapid disease progression.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.